Zevra Therapeutics Inc (ZVRA)
4.76
-0.06
(-1.24%)
USD |
NASDAQ |
May 16, 16:00
4.70
-0.06
(-1.26%)
After-Hours: 07:31
Zevra Therapeutics 1 Year Total Returns (Daily): 1.93% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.93% |
| May 15, 2024 | 10.55% |
| May 14, 2024 | 13.48% |
| May 13, 2024 | 15.60% |
| May 10, 2024 | 10.30% |
| May 09, 2024 | 13.54% |
| May 08, 2024 | 4.88% |
| May 07, 2024 | 5.40% |
| May 06, 2024 | 4.99% |
| May 03, 2024 | -3.22% |
| May 02, 2024 | -3.85% |
| May 01, 2024 | -12.71% |
| April 30, 2024 | -15.19% |
| April 29, 2024 | -15.74% |
| April 26, 2024 | -12.74% |
| April 25, 2024 | -19.14% |
| April 24, 2024 | -20.56% |
| April 23, 2024 | -21.84% |
| April 22, 2024 | -22.01% |
| April 19, 2024 | -25.41% |
| April 18, 2024 | -26.71% |
| April 17, 2024 | -25.52% |
| April 16, 2024 | -24.04% |
| April 15, 2024 | -23.81% |
| April 12, 2024 | -20.92% |
| Date | Value |
|---|---|
| April 11, 2024 | -19.15% |
| April 10, 2024 | -18.54% |
| April 09, 2024 | -15.69% |
| April 08, 2024 | -11.94% |
| April 05, 2024 | -11.88% |
| April 04, 2024 | -9.91% |
| April 03, 2024 | -9.37% |
| April 02, 2024 | -7.00% |
| April 01, 2024 | -6.18% |
| March 28, 2024 | 7.21% |
| March 27, 2024 | 9.19% |
| March 26, 2024 | 4.57% |
| March 25, 2024 | 3.11% |
| March 22, 2024 | 6.47% |
| March 21, 2024 | 8.85% |
| March 20, 2024 | 22.02% |
| March 19, 2024 | 23.96% |
| March 18, 2024 | 24.17% |
| March 15, 2024 | 31.87% |
| March 14, 2024 | 28.39% |
| March 13, 2024 | 41.44% |
| March 12, 2024 | 51.09% |
| March 11, 2024 | 48.43% |
| March 08, 2024 | 47.70% |
| March 07, 2024 | 46.40% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.69%
Minimum
Mar 18 2020
383.5%
Maximum
Jun 11 2021
-10.43%
Average
-22.10%
Median
Oct 18 2023
1 Year Total Returns (Daily) Benchmarks
| OptiNose Inc | -31.38% |
| Perspective Therapeutics Inc | 200.0% |
| Dare Bioscience Inc | -58.59% |
| Kodiak Sciences Inc | -35.74% |
| INmune Bio Inc | 49.73% |